The collaboration between the CSM and Dr. Rachid Benchaouir, Founder and CEO of the Coraliotech startup, started in 2014, when he was conducting joint research with the Departments of Marine Biology and Medical Biology, in the field of genetic diseases and DNA sequencing of corals.
The molecule discovered during this research is of major interest for the development of pharmacological and cosmetic products, both innovative and sustainable.
It helps protect skin cells against ultraviolet radiation and against particularly toxic chemical agents. These remarkable properties have been valued in the form of a patent application extended internationally, of which the CSM is co-owner.
Faced with the potential for innovative substances in corals, Mr. Benchaouir decided to create Coraliotech, with the support of the CSM. The Monegasque marine biotechnology startup has been part of the MonacoTech incubator since the end of 2017.
Read the full article : “The Monaco Scientific Center takes stake in the startup Coraliotech” by Wealth Monaco